Safety and Intrapulmonary Pharmacokinetics of Cefepime and Taniborbactam in Healthy Subjects
Clinical trial NCT04951505 · COMPLETED
Trial details
- NCT number
- NCT04951505
- Sponsor
- Venatorx Pharmaceuticals, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-06-29
- Primary completion
- 2021-09-27
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.